Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Delnor Community Hospital - Geneva
mi
from
Geneva, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Delnor Community Hospital - Geneva
mi
from
Geneva, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mason District Hospital
mi
from
Havana, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mason District Hospital
mi
from
Havana, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hinsdale Hematology Oncology Associates
mi
from
Hinsdale, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hinsdale Hematology Oncology Associates
mi
from
Hinsdale, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hopedale Medical Complex
mi
from
Hopedale, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hopedale Medical Complex
mi
from
Hopedale, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Provena St. Mary's Regional Cancer Center - Kankakee
mi
from
Kankakee, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Provena St. Mary's Regional Cancer Center - Kankakee
mi
from
Kankakee, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
La Grange Memorial Hospital
mi
from
La Grange, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
La Grange Memorial Hospital
mi
from
La Grange, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
McDonough District Hospital
mi
from
Macomb, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
McDonough District Hospital
mi
from
Macomb, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Good Samaritan Regional Health Center
mi
from
Mt. Vernon, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Good Samaritan Regional Health Center
mi
from
Mt. Vernon, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Community Cancer Center
mi
from
Normal, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields
mi
from
Olympia Fields, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields
mi
from
Olympia Fields, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Advocate Lutheran General Cancer Care Center
mi
from
Park Ridge, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Advocate Lutheran General Cancer Care Center
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Proctor Hospital
mi
from
Peoria, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Proctor Hospital
mi
from
Peoria, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Illinois Valley Community Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Perry Memorial Hospital
mi
from
Princeton, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Perry Memorial Hospital
mi
from
Princeton, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Center for Cancer Care at OSF Saint Anthony Medical Center
mi
from
Rockford, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Center for Cancer Care at OSF Saint Anthony Medical Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. Margaret's Hospital
mi
from
Spring Valley, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. Margaret's Hospital
mi
from
Spring Valley, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Regional Cancer Center at Memorial Medical Center
mi
from
Springfield, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Regional Cancer Center at Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Carle Cancer Center at Carle Foundation Hospital
mi
from
Urbana, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Carle Cancer Center at Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Elkhart General Hospital
mi
from
Elkhart, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Fort Wayne Medical Oncology and Hematology
mi
from
Fort Wayne, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Fort Wayne Medical Oncology and Hematology
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Methodist Cancer Center at Methodist Hospital
mi
from
Indianapolis, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Methodist Cancer Center at Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Howard Community Hospital
mi
from
Kokomo, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Howard Community Hospital
mi
from
Kokomo, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Clarian Arnett Cancer Care
mi
from
Lafayette, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Clarian Arnett Cancer Care
mi
from
Lafayette, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Saint Anthony Memorial Health Centers
mi
from
Michigan City, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Community Hospital
mi
from
Munster, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Community Hospital
mi
from
Munster, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Reid Hospital & Health Care Services
mi
from
Richmond, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Memorial Hospital of South Bend
mi
from
South Bend, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Saint Joseph Regional Medical Center
mi
from
South Bend, IN
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Saint Joseph Regional Medical Center
mi
from
South Bend, IN
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
McFarland Clinic, PC
mi
from
Ames, IA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mercy Capitol Hospital
mi
from
Des Moines, IA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mercy Capitol Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated:  10/5/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Status: Enrolling
Updated: 10/5/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials